Compass Therapeutics LLC — Form D/A

Compass Therapeutics LLC of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2018-07-16. The offering totals $170.2M, of which $110.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Timothy J AndersonDirector
CARL GORDONDirectorSAN DIEGO, CA
Stephen SquintoDirectorStamford, CT
Errik AndersonDirectorCambridge, MA
Errik AndersonExecutive OfficerCambridge, MA
Errik AndersonPromoterCambridge, MA
Steve TregayDirectorSan Carlos, CA
Ben AuspitzDirectorCambridge, MA
Philip FerneauDirectorHanover, NH
THOMAS J SCHUETZDirectorCAMBRIDGE, MA
THOMAS J SCHUETZExecutive OfficerCAMBRIDGE, MA
THOMAS J SCHUETZPromoterCAMBRIDGE, MA
STEVEN J SQUINTODirectorCAMBRIDGE, MA
CARL J GORDONDirectorCAMBRIDGE, MA
SARA J MANNLEExecutive OfficerCAMBRIDGE, MA
VERED J BISKER-LEIBExecutive OfficerCAMBRIDGE, MA
ERRIK J ANDERSONDirectorCAMBRIDGE, MA
ERRIK J ANDERSONPromoterCAMBRIDGE, MA
BEN J AUSPITZDirectorCAMBRIDGE, MA
BRUCE J STEELDirectorCAMBRIDGE, MA
JEB J LEDELLExecutive OfficerCAMBRIDGE, MA
DAMON J BANKSExecutive OfficerCAMBRIDGE, MA
WILL J EDENDirectorCAMBRIDGE, MA
PIOTR J BOBROWICZExecutive OfficerCAMBRIDGE, MA
STEVE J TREGAYDirectorCAMBRIDGE, MA

Other filings by this issuer (5)

FiledFormOfferingSold
2018-01-08D$50.0M$21.8M
2016-09-21D/A$170.2M$46.0M
2015-07-01D$121.0M$16.0M
2015-05-28D/A$1.0M$575K
2014-06-13D$1.0M$475K

More